Serum Antioxidant Status in Sickle Cell Disease Patients: Implications for Oxidative Stress and Disease Severity
DOI:
https://doi.org/10.22317/jcms.v9i2.1336Keywords:
Antioxidants, Anemia, Sickle Cell, Oxidative Stress, Reactive oxygenAbstract
Objectives: The main aim of this subject is to determine the oxidative status of Iraqi sickle cell anemic patients and then correlated with various biomarkers.
Methods: In this study, blood samples from 100 sickle cell anemic subjects were analyzed, and then compared with control group which consisting of 50 individuals without sickle cell anemia was established. Various biochemical techniques were employed to measure different oxidative stress markers and inflammatory mediators. Serum samples were collected from blood to determine the levels of antioxidants such as catalase (CAT), glutathione peroxidase (G-Px), reduced glutathione (GSH), and lipid-peroxidation product malondialdehyde (MDA).
Results: The results revealed that the levels of serum antioxidant activity (CAT), GSH, and G-Px were significantly reduced with (P < 0.05) in sickle cell anemic patients as compared with apparently control group. In contrast, the MDA level was significantly higher in sickle cell anemic patients than that found in the apparently control group.
Conclusion: In this work, there is an increased oxidative stress in sickle cell anemic patients, which is accompanied by a decrease in antioxidant activity and a rise in lipid peroxidation, leading to the intensification of sickle cell anemic symptoms in patients.
References
Johnson, K. M., Jiao, B., Ramsey, S. D., Bender, M. A., Devine, B., & Basu, A. (2023). Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance. Blood Advances, 7(3),365-374.
Wonkam, A. (2023). The future of sickle cell disease therapeutics restsin genomics. Disease Models & Mechanisms, 16(2),dmm049765.
Thein, M.S.; Igbineweka, N.E.; Thein, S.L. Sickle cell disease in the olderadult. Pathology 2017, 49, 1–9.
Piel, F.B.; Steinberg, M.H.; Rees, D.C. Sickle Cell Disease. N. Engl. J. Med. 2017, 377,305.
Al-Naama LM, Hassan MK, Mehdi JK. Association of erythrocytes antioxidant enzymes and their cofactors with markers of oxidative stress in patients withsickle cell anemia. Qatar Med J.2015;2015:14.
Perrone S, Tataranno ML, Stazzoni G, et al. Oxidative injury inneonatal erythrocytes. J Matern Fetal Neonatal Med.2012;25:104–108.
Biswal, S., Rizwan, H., Pal, S., Sabnam, S., Parida, P., & Pal, A. (2019). Oxidative stress, antioxidant capacity, biomolecule damage, and inflammation symptoms of sickle cell disease in children. Hematology, 24(1),1-9.
Nur E, Biemond BJ, Otten HM, et al. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. Am J Hematol. 2011;86:484–489.
Silva DG, Belini Junior E, de Almeida EA, et al. Oxidative stress in sickle cell disease: an overview of erythrocyte redox metabolism and current antioxidant therapeutic strategies. Free RadicBiol Med.2013;65:1101–1109.
Biswal, S., Rizwan, H., Pal, S., Sabnam, S., Parida, P., & Pal, A. (2019). Oxidative stress, antioxidant capacity, biomolecule damage, and inflammation symptoms of sickle cell disease in children. Hematology, 24(1),1-9.
Morris, C.R.; Suh, J.H.; Hagar, W.; Larkin, S.; Bland, D.A.; Steinberg, H.A.; Vichinsky, E.P.; Shigenaga, M.; Ames, B.; Kuypers, F.A.; et al. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood 2008, 111,402–410.
Nagababu, E.; Fabry, M.E.; Nagel, R.L.; Rifkind, J.M. Heme degradation and oxidative stress in murine models for hemoglobinopathies: Thalassemia, sicklecell disease and hemoglobin C. disease. Blood Cells Mol. Dis. 2008, 41,61–66.
Antwi-Boasiako, C., B. Dankwah, G., Aryee, R., Hayfron-Benjamin, C., S. Donkor, E., & D. Campbell, A. (2019). Oxidative profile of patients with sickle cell disease. Medical Sciences, 7(2),17.
Voskou, S.; Aslan, M.; Fanis, P.; Phylactides, M.; Kleanthous, M. Oxidative stress in the β-thalassemia and sickle cell disease. Redox. Biol. 2015, 6,226–239.
Akohoue, S.A.; Shankar, S.; Milne, G.L.; Morrow, J.; Chen, J.K.; Ajaiyi,W.U.; Buckowski, M.S. Energy expenditure, inflammation, and oxidative stress in steady- state adolescents with sickle cell anemia. Pediatr. Res. 2007, 61,233–238.
Yeruva, S., SharadaVaralakshmi, M., PavanGowtham, B., Hari Chandana, Y., & Krishna Prasad, P. E. S. N. (2021). Identification of sickle cell anemia using deep neural networks. Emerging Science Journal, 5(2), 200–210.
Kumar P, Raman T, Swain MM, et al. Hyperglycemiainduced oxidative- nitrosative stress induces inflammation and neurodegeneration via augmented tuberous sclerosis complex-2 (TSC-2) activation in neuronal cells. MolNeurobiol. 2017;54:238–254.
Kapoor R, Kakkar P. Protective role of morin, a flavonoid, against high glucose induced oxidative stress mediated apoptosis in primaryrat hepatocytes. PLoS One.2012;7:e41663.
Rotruck, J. T., Pope, A. L., Ganther, H. E., Swanson, A. B., Hafeman, D. G., & Hoekstra, W. (1973). Selenium: biochemical role as a component of glutathione peroxidase. Science, 179(4073),588-590.
Ama Moor, V. J., Pieme, C. A., ChetchaChemegne, B., Manonji, H., NjinkioNono, B. L., TchoulaMamiafo, C., ... &Tazoacha, A. (2016). Oxidative profile of sickle cell patients in a Cameroonian urban hospital. BMC Clinical Pathology, 16(1), 1-5.
Biswal, S., Rizwan, H., Pal, S., Sabnam, S., Parida, P., & Pal, A. (2019). Oxidative stress, antioxidant capacity, biomolecule damage, andinflammation symptoms of sickle cell disease in children. Hematology, 24(1),1-9.
Saka, W. A., Anigbogu, C. N., Kehinde, M. O., &Jaja, S. I. (2023). L-Arginine supplementation enhanced expression of glucose transporter (GLUT 1) in sickle cell anaemia subjects in the steady state. Current Research in Physiology, 6,100096.
Luo, J., Fan, J. B., & Wang, S. (2020). Recent progress of microfluidic devices for hemodialysis. Small, 16(9),1904076.
Bahal, M., Nyamati, S., Hegde, S., Kakkar, A., Sood, I., &Kalra, S. (2022). Estimation of Malondialdehyde Levels and Determination of Total Antioxidant Capacity in Serum and Saliva of Patient Affected with Sickle Cell Anemia. Journal of Indian Academy of Oral Medicine and Radiology, 34(4),380-384.
Antwi‐Boasiako, C., Dankwah, G. B., Aryee, R., Hayfron‐Benjamin, C., Aboagye, G., & Campbell, A. D. (2020). Correlation of lipid peroxidation and nitric oxide metabolites, trace elements, and antioxidant enzymes in patients with sickle cell disease. Journal of clinical laboratory analysis, 34(7),e23294.
Emokpae, A. M., Ojiefo, U. P., & Aisha, K. G. (2010). Antioxidant enzymes and acute phase proteins correlate with marker of lipid peroxide in adult Nigerian sickle cell diseasepatients.
Chirico EN, Pialoux V. Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMBLife.
;64:72–80.
Hameed, R. M. (2012). Evaluation of Lipid Peroxidation, Level of Selenium and Enzymatic Antioxidant Activity in Woman During Pregnancy and Abortion at First Trimester. kerbala journal of pharmaceutical sciences, (3).
Choudhary, M., Chaudhari, S., Gupta, T., Kalyane, D., Sirsat, B., Kathar, U., ... & Tekade, R. K. (2023). Stimuli-Responsive Nanotherapeutics for Treatment and Diagnosis of Stroke. Pharmaceutics, 15(4), 1036.
ÖZKAN, S., & ÖZDEMİR, E. (2022). ROLE OF BIO─ ACTIVE COMPOUNDS TO PREVENT OXIDATIVE DAMAGE IN MAIZE. Research & Reviews in Agriculture, Forestry and Aquaculture, 31.
Singh, N., Gr, S., & Mugesh, G. (2023). Antioxidant and Prooxidant Nanozymes: From Cellular Redox Regulation to Next‐Generation Therapeutics. Angewandte Chemie, e202301232.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Contemporary Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
